patient's treatment has now been appropriately modified.
Discussion
Our patient shows clinical and biochemical features pathognomonic of CTX.' Cataracts, which may be seen as early as age 15,' have been recorded in about 85% of all reported cases. It is stated that cataract extraction 'by young adulthood' is usually necessary.' Our patient's late presentation accounts for his relatively advanced age at surgery.
The typical lens opacity is described as 'zonular cortical' and is well illustrated in a recent review.' Our patient's opacities were more advanced than this.
We have found references to only three other ophthalmic complications in CTX, namely, xanthelasma deposition,' an increased content of sterols in the extraocular muscles,' and 'atrophy of the entire optic pathway.'4" Proptosis, however, is a hitherto undescribed clinical feature. In this case it is due to xanthoma deposition in the extraocular muscles and reflects the generalised tendency to xanthoma deposition, particularly in tendons, which affects the Achilles tendon most frequently but also the tibial tuberosities, triceps, and finger extensors. ' If untreated, CTX leads to an unpleasant early death from relentless neurological deterioration with spasticity, ataxia, bulbar palsy, incontinence, and dementia. 4 Psychiatric disorders may be prominent." Myocardial infarction may occur and has been recorded as young as age 36.' The prospect of halting or even reversing this decline by treatment with oral bile acid supplements makes it vitally important that this condition be promptly diagnosed.
Treatment with chenodeoxycholic acid is reported to have resulted in a favourable biochemical response, with return of plasma cholestanol levels nearly to normal.' Our patient was initially treated with ursodeoxycholic acid because it has a lower reported incidence of gastrointestinal side effects."' Failure of the biochemical abnormality to respond to ursodeoxycholic acid has been reported"' and is confirmed by our observations.
The mechanism of cataract formation in CTX is of some interest in view of the abnormalities of lipid metabolism in this disease. We have shown that there is a raised level of cholestanol in the cataractous lens in CTX compared with senile cataract (report in preparation). However, we have now demonstrated that CTX must also be included in the differential diagnosis of proptosis. 
